233.00
+4.65
+(2.04%)
At close: January 10 at 1:10:21 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 11 | 14 | 15 |
Avg. Estimate | 78.16B | 75.07B | 318.33B | 338.18B |
Low Estimate | 76.52B | 73.89B | 315.88B | 331.22B |
High Estimate | 79.93B | 76.13B | 322.36B | 348.19B |
Year Ago Sales | 72.25B | 68.41B | 293.96B | 318.33B |
Sales Growth (year/est) | 8.18% | 9.73% | 8.29% | 6.24% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ABG.F | -- | -- | -- | -- |
S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 12/13/2024 |
Maintains | Baird: Outperform to Outperform | 11/7/2024 |
Maintains | UBS: Buy to Buy | 11/7/2024 |
Maintains | Barclays: Overweight to Overweight | 11/7/2024 |
Maintains | Evercore ISI Group: Outperform to Outperform | 11/7/2024 |
Maintains | JP Morgan: Overweight to Overweight | 8/21/2024 |